Funder
Heart and Stroke Foundation of Canada
Canadian Institutes of Health Research
Providence Health Care
Mitacs
Marfan Foundation
Reference45 articles.
1. Ancion, A., Tridetti, Julien, Nguyen Trung, Mai-Linh, Oury, Cécile, Lancellotti, Patrizio, n.d. A Review of the Role of Bradykinin and Nitric Oxide in the Cardioprotective Action of Angiotensin-Converting Enzyme Inhibitors: Focus on Perindopril. Cardiology and Therapy 8. Available at: https://doi.org/10.6084/m9.figshare.9896510.
2. Endothelial dysfunction: a marker of atherosclerotic risk;Bonetti;Arterioscler. Thromb. Vasc. Biol.,2003
3. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy;Brenner;N. Engl. J. Med.,2001
4. Nitric oxide: a physiological mediator of the type 2 (AT2) angiotensin receptor;Carey;Acta Physiol. Scand.,2000
5. The pleiotropic effects of angiotensin receptor blockers | enhanced reader;Chrysant;J. Clin. Hypertens.,2006